Prognostic Value of Walk Distance, Work, Oxygen Saturation, and Dyspnea During 6-Minute Walk Test in COPD Patients

被引:37
|
作者
Golpe, Rafael [1 ]
Perez-de-Llano, Luis A. [1 ]
Mendez-Marote, Lidia [1 ]
Veres-Racamonde, Alejandro [1 ]
机构
[1] Hosp Univ Lucus Augusti, Serv Neumol, Lugo 27003, Spain
关键词
6-min walk test; prognosis; mortality; pulmonary diseases; chronic obstructive; work capacity evaluation; oximetry; DESATURATION; OBSTRUCTION; PREDICTORS; MORTALITY; SURVIVAL; CAPACITY;
D O I
10.4187/respcare.02290
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BACKGROUND: Distance walked during the 6-min walk test (6MWT) predicts mortality in COPD. The body weight of the patient affects the work required to walk. Calculated work during the 6MWT (6MWT work) may account for differences in walk distance resulting from change in body weight. Thus, 6MWT work might be a better predictor of mortality than distance walked. This study was designed to test this hypothesis and to assess if other variables measured during the 6MWT, like continuous oximetry recording, offered additional prognostic information. METHODS: This was a retrospective analysis of prospectively collected data; 104 COPD patients were studied. 6MWT was performed in all cases. 6MWT work was calculated as body weight (in kg) x distance walked (in in). Receiver operating characteristic curves were used to assess the value of variables to predict mortality. Additional analysis was performed using Kaplan-Meier survival plots and Cox proportional hazards regression models. RESULTS: Mean follow-up was 590 +/- 472 d. Eleven subjects (10.6%) died. 6MWT work was not better than distance walked to predict mortality (area under the curve 0.77 for 6MWT work vs 0.80 for distance; difference 0.03, 95% CI -0.05 to 0.12, P = .45). Subjects who died had more dyspnea (measured using the Borg scale) after the 6MWT (8.5 vs 4.0, P < .001), lower baseline Spia, (85% vs 93%, P = .001), worse oxygen saturation during the 6MWT (mean S-pO2 while walking 74.0% vs 86.6%, P = .02) and walked less distance (255 m vs 480 m, P = .001). On multivariate analysis, only 6MWT distance and dyspnea after the test correlated independently with mortality (P = .005 for both variables). CONCLUSIONS: 6MWT work was not more useful than 6MWT distance to predict mortality. The study confirms that 6MWT distance and dyspnea on exertion are key elements in prognostic evaluation in COPD, while the value of exercise oxygen desaturation is less clear.
引用
收藏
页码:1329 / 1334
页数:6
相关论文
共 50 条
  • [41] RECOVERY PROCESS AFTER 6-MINUTE WALK TEST IN STABLE COPD PATIENTS
    Satake, Masahiro
    Shioya, Takanobu
    Takahashi, Hitomi
    Sugawara, Keiyu
    Kasai, Chikage
    Kiyokawa, Noritaka
    Watanabe, Toru
    Sato, Sayaka
    Kawagoshi, Atsuyoshi
    RESPIROLOGY, 2014, 19 : 118 - 118
  • [42] 6-minute walk test with headphones
    Boaventura, Rita
    Almeida, Leonor
    Machado, Francisco
    Moreira, Ermelinda
    Amorim, Pedro
    Pimentel, Ana
    Pipa, Joana Chaves
    Neves, Andreia
    Teles, Patricia
    Martins, Natalia
    Drummond, Marta
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [43] DIASTOLIC DYSFUNCTION IN REDUCED 6-MINUTE WALK TEST DISTANCE IN CIRRHOTIC PATIENTS
    Munoz-Martinez, Sergio G.
    Marquez-Guillen, Ernesto
    Chaires-Garza, Luis
    Calle-Rodas, Daniel A.
    Toapanta-Yanchapaxi, Liz N.
    Paez-Zayas, Victor
    Marroquin-Reyes, Jose Daniel
    Tepox, Alejandra
    de Arredondo, Humberto Paredes-Martinez
    Hernandez-Reyes, Pablo
    Garcia-Juarez, Ignacio
    GASTROENTEROLOGY, 2018, 154 (06) : S1149 - S1149
  • [44] Does the 6-minute walk test predict nocturnal oxygen desaturation in patients with moderate to severe COPD?
    Iliaz, Sinem
    Cagatay, Tulin
    Bingol, Zuleyha
    Okumus, Gulfer
    Iliaz, Raim
    Kuran, Goksen
    Kiyan, Esen
    Cagatay, Penbe
    CHRONIC RESPIRATORY DISEASE, 2015, 12 (01) : 61 - 68
  • [45] The Prognostic Importance of the 6-Minute Walk Test in AL Amyloidosis
    Cohen, Oliver C.
    Sathyanath, Ananth
    Ravichandran, Sriram
    Law, Steven
    Manwani, Richa
    Foard, Darren
    Sachchithanantham, Sajitha
    Mahmood, Shameem
    Martinez-Naharro, Ana
    Fontana, Marianna
    Whelan, Carol
    Hawkins, Philip N.
    Lachmann, Helen J.
    Gillmore, Julian D.
    Wechalekar, Ashutosh D.
    BLOOD, 2020, 136
  • [46] 6-minute walk testing in COPD: is it reproducible?
    Criner, G.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 38 (02) : 244 - 245
  • [47] Prognostic Usefulness of the 6-Minute Walk Test in Patients With Severe Aortic Stenosis
    Castillo-Moreno, Juan A.
    Garcia-Escribano, Irene A.
    Martinez-Pascual-de-Riquelme, Miryam
    Jaulent-Huertas, Leticia
    Dau-Villarreal, Derek F.
    Rubio-Paton, Ramon
    Giner-Caro, Jose A.
    Bonaque-Gonzalez, Juan C.
    Consuegra-Sanchez, Luciano
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 118 (08): : 1239 - 1243
  • [48] Value of Impedance Cardiography during 6-Minute Walk Test in Pulmonary Hypertension
    Tonelli, Adriano R.
    Alkukhun, Laith
    Arelli, Vineesha
    Ramos, Jose
    Newman, Jennie
    McCarthy, Kevin
    Pichurko, Bohdan
    Minai, Omar A.
    Dweik, Raed A.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2013, 6 (06): : 474 - 480
  • [49] Reproducibility of the 6-Minute Walk Test for Ambulatory Oxygen Prescription
    Chatterjee, Arjun B.
    Rissmiller, Richard W.
    Meade, Kyle
    Paladenech, Connie
    Conforti, John
    Adair, Norman E.
    Haponik, Edward F.
    Chin, Robert, Jr.
    RESPIRATION, 2010, 79 (02) : 121 - 127
  • [50] Is 6-minute walk test of value in congestive heart failure?
    Schaufelberger, M
    Swedberg, K
    AMERICAN HEART JOURNAL, 1998, 136 (03) : 371 - 372